Scientific Program – GYNECOLOGY

Friday, November 28 & Saturday, November 29, 2025

Friday, November 28

08:30-09:00 GOOD MORNING ROME PLENARY LECTURE Live streamed from HALL A
Capsule A decade ago, a pionering procedure was successfully launched
Chairpersons Zion Ben Rafael, Israel
Rene Frydman, France
08:30-08:55 Pioneering uterus transplantation: Reflections on breakthroughs and deliveries
Mats Brännström, Sweden
08:55-19:00 Discussion

 

09:00-10:00 THE GUT, VAGINAL AND BLADDER MICROBIOME IN WOMEN’S LIFESPAN HALL C
Capsule Microbiome, so much information, yet so little clinical conclusion
Chairpersons Andrea Genezzani, Italy
Mark Brincat, Malta
09:00-09:15

The gut microbiome. The great director of women’s health
Vincenzo Stanghellini, Italy

09:15-09:20

Discussion

09:20-09:35

The vaginal and bladder microbiome: The secret dialogue, in the lifespan
Alessandra Graziottin, Italy

09:35-09:40

Discussion

09:40-09:55

The uterine microbiome as a marker of female infertility
Gemma Fabozzi, Italy

09:55-10:00

Discussion

 

10:00-10:30 Coffee break, visit the exhibition, and e-poster viewing

 

10:30-12:00 NOVEL GLOBAL GUIDANCE ON POI: TOWARDS PERSONALIZED MEDICINE HALL C
Capsule
Chairpersons  Nick Panay, UK
Micheline Misrahi, France
10:30-10:55

Genetics of POI: a leap for diagnosis and personalized medicine in novel 2024 guidelines
Micheline Misrahi, France

10:55-11:15

Autoimmunity in POI
Johannes Ott, Austria

11:15-11:40

Short and long term cardiometabolic risks of POI
Rossella Nappi, Italy

11:40-12:00

Update of POI guidelines (from ESHRE and our latest searches of literature for IMS POI recommendations)
Nick Panay, UK

 

12:00-12:05 Short break

 

12:05-13:05 INDUSTRY SUPPORTED SESSION HALL A and B

 

13:05-14:00 Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions

 

14:00-15:00 INDUSTRY SUPPORTED SESSION HALL A and B

 

15:00-15:05 Short break

 

15:05-16:35 TBA HALL C
Capsule
Chairpersons Andrea Genazzani, Italy
Alessandra Graziottin, Italy
15:05-15:35

15:05
15:15
15:25

Debate: Patients with early menopause should be treated continuously to prevent chronic diseases

For: Nick Panay, UK
Against: Mark Brincat, Malta
Discussion

15:35-16:05

15:35
15:45
15:55

Debate: Menopause symptoms and diseases can be managed without Menopausal HT?

For: Santiago Palacios, Spain
Against: Rossella Nappi, Italy
Discussion

16:05-16:35

16:05
16:15
16:25

Debate: Lichen Sclerosus or Vulvodynia

Lichen Sclerosis: Zdenko Vizintin, Slovenia
Vulvodynia: Mark Brincat, Malta
Discussion

 

16:35-17:00 Coffee break, visit the exhibition, and e-poster viewing

 

17:00-18:30 MENOPAUSE: BEYOND THE MINIMISATION OF HOT FLUSHES HALL C
Capsule
Chairpersons 

Rossella Nappi, Italy
TBA

17:00-17:15

Have we gone a full circle and should offer HT for all?
Mark Brincat, Malta

17:15-17:20

Discussion

17:20-17:40

Predicting, preventing and optimising cardiometabolic menopause outcomes in “at risk” women
Tommaso Simoncini, Italy

17:40-17:45

Discussion

17:45-18:00

The bladder after the menopause: A call for action
Andrea Genazzani, Italy

18:00-18:05

Discussion

18:05-18:25

Osteoarthritis: Why estrogens have a specific role
Alessandra Graziottin, Italy

18:25-18:30

Discussion

Saturday, November 29

08:30-10:00 GOOD MORNING ROME PLENARY LECTURE Live streamed from HALL A
Capsule
Chairpersons

Bart Fauser, Netherlands
Jacques Donnez, Belgium

08:30-08:55

Endometriosis before and during pregnancy
Paolo Vercellini, Italy

08:55-09:00 Discussion

 

09:00-10:30 SLS – SOCIETY OF LAPAROSCOPIC & ROBOTIC SURGEONS HALL C
Capsule
Chairpersons Jessica Ybanez MoranoUSA
   

 

10:30-11:00 Coffee break, visit the exhibition, and e-poster viewing

 

11:00-12:30 FERTILITY PRESERVATION HALL C
Capsule
Chairpersons
11:00-11:15 Fertility – sparing management in recurrent gynecological cancer
11:15-11:20 Discussion
11:20-11:35 Fertility preservation in borderline and malignant tumors
11:35-11:40 Discussion
11:40-12:10

11:40
11:50
12:00

Debate: Is there room for ovarian tissue cryopreservation for breast cancer patients? What is the risk?

No:
Yes:
Discussion

12:10-12:25 What are the differences between fertility preservation for benign diseases and malignancy?
12:25-12:30 Discussion

 

12:30-13:30 Lunch break, visit the exhibition, and e-poster viewing

 

13:30-15:00 PCOS HALL C
Capsule
Chairpersons

Bart Fauser, Netherlands
TBA

13:30-14:00

13:30
13:40
13:50

Debate: PCOS (new section) Is the diagnostic criteria for PCOS adequate for effective management?

Yes: TBA
No: Joop Laven, Netherlands
Discussion

13:50-14:05

SEMaglutides (GLP1 antagonist) and PCO
Signe Sørensen Torekov, Denmark

14:05-14:10 Discussion
14:10-14:25

Challenges in diagnosing PCOS in adolescents
Elene Asanidze, Georgia

14:25-14:30

Discussion

 

15:00-16:30 TBA HALL C
Capsule
Chairpersons

15:00-15:15

There is a need for androgen therapy after menopause
Andrea Genazzani, Italy

15:15-15:20

Discussion

15:20-15:40 Neurokinin-3 receptor antagonists: A novel approach to treating menopausal vasomotor symptoms
Santiago Palacios, Spain
15:40-15:45

Discussion

15:45-16:05

Sexual arousal: The winning strategy
Alessandra Graziottin, Italy

16:05-16:10

Discussion

16:10-16:25

Managing sexuality issues in patients contraindicated to or unresponsive to estrogens and androgens
Rossella Nappi, Italy

16:25-16:30

Discussion

 

Skip to content